Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CABOZANTINIB S-MALATE Cause Rash papular? 23 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 23 reports of Rash papular have been filed in association with CABOZANTINIB S-MALATE (CABOMETYX). This represents 0.1% of all adverse event reports for CABOZANTINIB S-MALATE.

23
Reports of Rash papular with CABOZANTINIB S-MALATE
0.1%
of all CABOZANTINIB S-MALATE reports
1
Deaths
4
Hospitalizations

How Dangerous Is Rash papular From CABOZANTINIB S-MALATE?

Of the 23 reports, 1 (4.3%) resulted in death, 4 (17.4%) required hospitalization.

Is Rash papular Listed in the Official Label?

Yes, Rash papular is listed as a known adverse reaction in the official FDA drug label for CABOZANTINIB S-MALATE.

What Other Side Effects Does CABOZANTINIB S-MALATE Cause?

Diarrhoea (8,282) Fatigue (6,819) Off label use (5,245) Nausea (4,341) Decreased appetite (4,076) Blood pressure increased (2,939) Malignant neoplasm progression (2,718) Palmar-plantar erythrodysaesthesia syndrome (2,706) Weight decreased (2,657) Stomatitis (2,560)

What Other Drugs Cause Rash papular?

ADAPALENE (4,217) AVOBENZONE\OCTISALATE\OCTOCRYLENE (3,293) ADALIMUMAB (1,324) DUPILUMAB (698) ETANERCEPT (466) AVOBENZONE\HOMOSALATE\OCTINOXATE\OCTISALATE\OXYBENZONE (451) NAPROXEN (333) LEVOTHYROXINE (313) APIXABAN (306) LANSOPRAZOLE (300)

Which CABOZANTINIB S-MALATE Alternatives Have Lower Rash papular Risk?

CABOZANTINIB S-MALATE vs CAFFEINE CABOZANTINIB S-MALATE vs CALASPARGASE PEGOL CABOZANTINIB S-MALATE vs CALASPARGASE PEGOL-MKNL CABOZANTINIB S-MALATE vs CALCIFEDIOL CABOZANTINIB S-MALATE vs CALCIPOTRIENE

Related Pages

CABOZANTINIB S-MALATE Full Profile All Rash papular Reports All Drugs Causing Rash papular CABOZANTINIB S-MALATE Demographics